PUBLIC PRESSURE across the world may have prompted one of the world's biggest pharma multinationals to enter into an agreement with a non-profit organisation that will source and supply generic versions of its topline tuberculosis (TB) drug in dozens of low- and middle-income countries (LMICs) fighting this disease that kills two million people annually. It is a new kind of pact that Johnson & Johnson (J&J) has finally concluded with the UN-backed Stop TB Partnership, whose Global Drug Facility (GDF) purchases and makes TB drugs available at more affordable rates to a host of countries struggling with a heavy load of TB.
This is a significant development, because J&J's bedaquiline-it is on the World Health Organization (WHO)'s list of essential medicines combats the lethal multidrug-resistant TB (MDR TB), which afflicts more of the poor and those with HIV than others. Over the past two years, close to half a million new cases have been registered annually. So there was a celebration of sorts when the deal was announced on July 13, allowing GDF “to tender, procure, and supply generic versions of SIRTURO® (bedaquiline) for the majority of lowand middle-income countries, including countries where patents remain in effect." But, this deal is not the best way to fight the scourge of TB, because it excludes far too many countries.
Denne historien er fra August 01, 2023-utgaven av Down To Earth.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra August 01, 2023-utgaven av Down To Earth.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.